CLINICAL TRIALS

 

 

Clinical Trials, Tuesday 8 December 2020

08:50

Organiser's welcome remarks

Panel discussion
09:00

Keynote Panel: The digital opportunity for pharma– New technology, new investments, new opportunities

Moderator: Howard Califano, Innovation Centre Director, Singapore-MIT Alliance for Research and Technology
Carl Firth, Chief Executive Officer, ASLAN Pharmaceuticals
Nilesh Wadhwa, Director, New Ventures And Transactions, Johnson & Johnson Innovation, Asia Pacific, Johnson & Johnson
Dr Stephen Christopher, Regional Medical Lead, APAC, WHC and EP, Bayer
Kulbir Sandhu, APAC Regional Head, VP of Digital Strategy, Roche Pharma
Panel discussion
10:00

Keynote Panel: Creating a collaborative drug development ecosystem

Moderator: Sharon Chan, Head JLABS at Shanghai, Johnson & Johnson
Vishal Doshi, Chief Executive Officer, AUM Biosciences
Raymond Stevens, CEO and Co-founder, ShouTi Pharma
Andy Li, CEO, BioSense
Kevin Chen, CEO, Elixiron
Naheed Kurji, Co-founder, President and CEO, Cyclica Inc.
Sebastian Schaefer
Clinical Trials
11:00

Enleofen Bio: First-in-class therapeutics for fibro-inflammatory diseases (preclinical)

Sebastian Schaefer, Co-Founder, Enleofen Bio Pte Ltd
John Patava
Clinical Trials
11:30

Moving from conventional clinical trials to adaptive clinical trials

John Patava, Chief Operating Officer, AUM Biosciences
Sophie Tsou
Clinical Trials
12:00

Challenges in development of biosimilars and biosimilarity assessment – statistical perspective

Sophie Tsou, Associate Investigator, Division Of Biostatistics And Bioinformatics, National Health Research Institutes
Lisa Kim
Clinical Trials
12:30

Global industry adopted clinical project management competencies

Lisa Kim, Director of Capstone and Lecturer, Rutgers School of Health Professions
Huren Sivaraj
Clinical Trials
13:00

Singapore’s cancer clinical trials ecosystem – Challenges and solutions for stakeholders

Huren Sivaraj, Chief Executive Officer And Co-Founder, Oncoshot Ltd
Lilian Chow
Clinical Trials
13:30

Panel: Clinical trials in China

Moderator: Lilian Chow, VP of Clinical Operations and Regulatory Affairs, Cerecin
Dr Daniel Liu, Chief Scientific Officer, Clinical Service Center
PJ Chen, Senior Vice President, Clinical Development, APRINOIA Therapeutics
Joe Zhang, CEO, BJ Bioscience Inc.
Da Liu, Managing Director, China Resources Life Science Fund
Dr Jing Ping Yeo
Clinical Trials
14:30

Panel: Partnering to improve quality in clinical trials

Moderator: Dr Jing Ping Yeo, Director, Research Integrity, Compliance and Ethics, SingHealth
Hyejin Shin, Director, Group Leader, Clinical Qa, Samsung Bioepis
Tam C Nguyen, Deputy Director Of Research, St Vincent's Hospital Melbourne
Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo Pharma
Sunil Pandita, Manager Clinical Quality Assurance, Abbott Lab
Chris Hardesty
Clinical Trials
15:30

Panel: Transforming clinical trials with technology

Moderator: Chris Hardesty, Director, Healthcare & Life Sciences, KPMG
Mrunalini Jagtap, Data Management Lead, SICS, A*STAR
Dr Duc Viet Nguyen, Scientific Manager, NGF Bioenterprise
Jitesh Bhatt, VP - Clinical Product, Wellthy Therapeutics
Vidhu Sethi, Global Medical Affairs - Pain Category, GlaxoSmithKline
Panel discussion
Clinical Trials
16:30

Panel: The future of clinical trials in Asia

Moderator: Shubhangi Desai, Director Clinical Trial Management, Abbott
Dennis Teng, Medical Director, Abbvie
Dr Shubhadeep Sinha, Senior Vice President and Medical Director, Global Head of department - Clinical Trials, Medical Affairs, Pharmacovigilance, Hetero Drugs Ltd
Vincenzo Teneggi, Senior Director, Galapagos GmbH
last published: 09/Dec/20 03:45
BOOK NOW

 

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738